Shares of Yield10 Bioscience Inc (NASDAQ:YTEN) dropped 0% during mid-day trading on Tuesday . The stock traded as low as $1.37 and last traded at $1.49. Approximately 100 shares were traded during trading, a decline of 100% from the average daily volume of 191,416 shares. The stock had previously closed at $1.49.

The company has a market cap of $14.39 million, a PE ratio of -0.44 and a beta of 3.21. The company has a debt-to-equity ratio of 0.08, a quick ratio of 8.45 and a current ratio of 8.45.

Yield10 Bioscience (NASDAQ:YTEN) last announced its quarterly earnings data on Thursday, May 10th. The specialty chemicals company reported ($0.24) earnings per share (EPS) for the quarter. Yield10 Bioscience had a negative net margin of 1,410.88% and a negative return on equity of 131.88%. The company had revenue of $0.06 million for the quarter. analysts anticipate that Yield10 Bioscience Inc will post -4.5 EPS for the current year.

Several hedge funds and other institutional investors have recently made changes to their positions in YTEN. Renaissance Technologies LLC grew its stake in shares of Yield10 Bioscience by 288.6% during the 4th quarter. Renaissance Technologies LLC now owns 79,576 shares of the specialty chemicals company’s stock valued at $141,000 after buying an additional 59,100 shares during the period. Anson Funds Management LP purchased a new stake in Yield10 Bioscience during the 4th quarter worth $277,000. Finally, Sabby Management LLC purchased a new stake in Yield10 Bioscience during the 4th quarter worth $381,000. 8.95% of the stock is owned by institutional investors.

About Yield10 Bioscience

Yield10 Bioscience, Inc, an agricultural bioscience company, engages in developing disruptive technologies for enhancing crop yield in the United States and Canada. The company, through its Smart Carbon Grid for Crops and T3 platforms, is involved in improving fundamental crop yield through enhanced photosynthetic carbon capture, as well as increased carbon utilization efficiency to increase seed yield.

Receive News & Ratings for Yield10 Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Yield10 Bioscience and related companies with's FREE daily email newsletter.